To identify molecular mechanisms that may mediate resistance to mitochondrial Kv1.3 inhibitors PAPTP and PCARBT in multiple myeloma and to counteract them, we aimed to generate PCARBTP- and PAPTP-resistant cell lines. Here, KCNA3 is linked to plasma cell myeloma.